ERBB2 and cancer: However, this receptor is not present in normal brain cells and tissues.68 The elevated level of HER2 in different cancers has made it an appropriate target for CAR T therapy.69 Patients were treated with HER2 trastuzumab (herceptin) monoclonal antibody targeting the HER2 receptor.